Covaxin Phase 1 Trial Clears Lancet Review - The Sikh Times
Politics

Covaxin Phase 1 Trial Clears Lancet Review

New Delhi: 22 Jan 21 Covaxin, India’s first indigenous vaccine against COVID-19, showed enhanced immune response without any serious side effects in the Phase 1 trials, according to the results published in well-respected Lancet Infectious Disease journal on Friday.Similar peer-reviewed studies for the Phase 2 are still awaited and Phase 3 trials are ongoing even as the government continues to give out the jabs to lakhs of front-line workers. While the first two phases of vaccine trials usually focus on their safety, the third stage generally determines its efficacy.

Related posts

Portrait of Netaji Subhash Chandra Bose unveiled by the President at Rashtrapati Bhavan

thesikh

Amit Shah To Visit Delhi Police Headquarters As Farmers Stick To Rally

thesikh

Farmers’ Union Seeks Delhi Top Cop’s Permission For Protest At Ramlila Maidan

thesikh

Farmers’ Nationwide Hunger Strike Today

thesikh

Delhi High Court Orders Rs 10 Lakh Compensation To Family

thesikh

Mamata Banerjee’s Big Bengal Announcement

thesikh

Leave a Comment